Epigeneitc medicine for brain cancer

TippingPoint is a UCSF spinout that has developed a first-in-class screening platform to generate a better understanding of how the epigenome (how our DNA is packaged) drives and maintains disease. This platform has potential applications in central nervous system disorders including Alzheimer’s disease, brain cancers, and more.

Under the radar for now - more info soon.